| Title : A novel dipeptidyl peptidase IV inhibitor DA-1229 ameliorates streptozotocin-induced diabetes by increasing beta-cell replication and neogenesis - Cho_2011_Diabetes.Res.Clin.Pract_91_72 |
| Author(s) : Cho JM , Jang HW , Cheon H , Jeong YT , Kim DH , Lim YM , Choi SH , Yang EK , Shin CY , Son MH , Kim SH , Kim HJ , Lee MS |
| Ref : Diabetes Res Clin Pract , 91 :72 , 2011 |
| Abstract : Cho_2011_Diabetes.Res.Clin.Pract_91_72 |
| ESTHER : Cho_2011_Diabetes.Res.Clin.Pract_91_72 |
| PubMedSearch : Cho_2011_Diabetes.Res.Clin.Pract_91_72 |
| PubMedID: 21093089 |
Cho JM, Jang HW, Cheon H, Jeong YT, Kim DH, Lim YM, Choi SH, Yang EK, Shin CY, Son MH, Kim SH, Kim HJ, Lee MS (2011)
A novel dipeptidyl peptidase IV inhibitor DA-1229 ameliorates streptozotocin-induced diabetes by increasing beta-cell replication and neogenesis
Diabetes Res Clin Pract
91 :72
Cho JM, Jang HW, Cheon H, Jeong YT, Kim DH, Lim YM, Choi SH, Yang EK, Shin CY, Son MH, Kim SH, Kim HJ, Lee MS (2011)
Diabetes Res Clin Pract
91 :72